Stocks of the Hour: Chimeric Therapeutics, Apollo Minerals, Morella Corporation
Stocks of the Hour: Chimeric Therapeutics, Apollo Minerals, Morella Corporation
Chimeric Therapeutics (ASX:CHM) announced the successful treatment of the third participant, required to complete the fourth and final planned dose escalation cohort, in the CHM 1101 Phase 1A clinical trial, has been completed at City of Hope. In response, Jennifer Chow, CEO and Managing Director commented, "We look forward to providing an update on the safety and efficacy from the trial before the end of the year." Shares are trading 11.43 per cent higher at 3.9 cents.
嵌合治療公司(澳大利亞證券交易所市場代碼：CHM)宣佈，在CHM 1101期1A臨床試驗中，完成第四個也是最後一個計劃劑量遞增隊列所需的第三個參與者的成功治療已經在希望之城完成。對此，董事首席執行官兼董事總經理詹妮弗·周表示：“我們期待著在年底前提供該試驗的安全性和有效性的最新情況。”該公司股價上漲11.43%，至3.9美分。
Apollo Minerals (ASX:AON) has acquired a high quality European Copper Project, containing the Belgrade Copper Project, in Serbia. In response, Managing Director, Mr Neil Inwood, commented: "Serbia is currently Europe's second-largest copper producer and I am convinced there are world class sedimentary-hosted copper discoveries to be made in the region." Shares are trading 28.57 per cent higher at 3.6 cents.
Apollo Minerals(澳大利亞證券交易所股票代碼：AON)在塞爾維亞收購了一個高質量的歐洲銅礦專案，其中包括貝爾格勒銅礦專案。對此，董事總經理尼爾·因伍德先生表示：“塞爾維亞目前是歐洲第二大銅生產國，我相信該地區將發現世界級的沉積容礦銅礦。”該公司股價上漲28.57%，至3.6美分。
Morella Corporation (ASX:1MC) announced that lithium mineralisation has been confirmed from their recent shallow drilling at Carvers Lithium Project at North Big Smoky. In response, Managing Director, James Brown said, "With the groundwork laid by these findings, we are well positioned to embark on further analysis of the deeper brine target at Cavers." Shares are trading flat at 0.65 cents
莫雷拉公司(澳大利亞證券交易所股票代碼：1MC)宣佈，他們最近在North Big Smoky的卡弗斯鋰專案的淺層鑽探證實了鋰的礦化。對此，董事總裁詹姆斯·布朗表示：“有了這些發現奠定的基礎，我們就可以開始對洞穴更深的鹵水目標進行進一步的分析。”股票交易持平於0.65美分
譯文內容由第三人軟體翻譯。